Hyperviscosity Syndrome in Paraprotein Secreting Conditions Including Waldenstrom Macroglobulinemia

Allison Weaver; Samuel Rubinstein; Robert F. Cornell

doi:10.3389/fonc.2020.00815

Hyperviscosity Syndrome in Paraprotein Secreting Conditions Including Waldenstrom Macroglobulinemia

Allison Weaver, Samuel Rubinstein, Robert F. Cornell

Research output: Contribution to journal › Review article › peer-review

Abstract

Hyperviscosity syndrome is a serious complication associated with high levels of paraproteins in patients with hematological malignancies. Therapeutic advances in disease control may reduce the incidence of hyperviscosity syndrome; however, management of acute cases requires an understanding of key symptoms and prompt treatment to mitigate serious consequences.

Original language	English (US)
Article number	815
Journal	Frontiers in Oncology
Volume	10
DOIs	https://doi.org/10.3389/fonc.2020.00815
State	Published - May 19 2020
Externally published	Yes

Keywords

chemotherapy
hyperviscosity
lymphoma
plasma exchange
Waldenstrom

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.3389/fonc.2020.00815

Cite this

@article{b8fd0457c88f4fc1a3b0dee5c6cc87a1,

title = "Hyperviscosity Syndrome in Paraprotein Secreting Conditions Including Waldenstrom Macroglobulinemia",

abstract = "Hyperviscosity syndrome is a serious complication associated with high levels of paraproteins in patients with hematological malignancies. Therapeutic advances in disease control may reduce the incidence of hyperviscosity syndrome; however, management of acute cases requires an understanding of key symptoms and prompt treatment to mitigate serious consequences.",

keywords = "chemotherapy, hyperviscosity, lymphoma, plasma exchange, Waldenstrom",

author = "Allison Weaver and Samuel Rubinstein and Cornell, {Robert F.}",

note = "Publisher Copyright: {\textcopyright} Copyright {\textcopyright} 2020 Weaver, Rubinstein and Cornell.",

year = "2020",

month = may,

day = "19",

doi = "10.3389/fonc.2020.00815",

language = "English (US)",

volume = "10",

journal = "Frontiers in Oncology",

issn = "2234-943X",

publisher = "Frontiers Media S. A.",

}

TY - JOUR

T1 - Hyperviscosity Syndrome in Paraprotein Secreting Conditions Including Waldenstrom Macroglobulinemia

AU - Weaver, Allison

AU - Rubinstein, Samuel

AU - Cornell, Robert F.

PY - 2020/5/19

Y1 - 2020/5/19

N2 - Hyperviscosity syndrome is a serious complication associated with high levels of paraproteins in patients with hematological malignancies. Therapeutic advances in disease control may reduce the incidence of hyperviscosity syndrome; however, management of acute cases requires an understanding of key symptoms and prompt treatment to mitigate serious consequences.

AB - Hyperviscosity syndrome is a serious complication associated with high levels of paraproteins in patients with hematological malignancies. Therapeutic advances in disease control may reduce the incidence of hyperviscosity syndrome; however, management of acute cases requires an understanding of key symptoms and prompt treatment to mitigate serious consequences.

KW - chemotherapy

KW - hyperviscosity

KW - lymphoma

KW - plasma exchange

KW - Waldenstrom

UR - http://www.scopus.com/inward/record.url?scp=85085871214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85085871214&partnerID=8YFLogxK

U2 - 10.3389/fonc.2020.00815

DO - 10.3389/fonc.2020.00815

M3 - Review article

AN - SCOPUS:85085871214

SN - 2234-943X

VL - 10

JO - Frontiers in Oncology

JF - Frontiers in Oncology

M1 - 815

ER -

Hyperviscosity Syndrome in Paraprotein Secreting Conditions Including Waldenstrom Macroglobulinemia

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this